ArticleCancer medicine2025

A Phase I/IB, Open Label, Dose Finding Study to Evaluate Safety, Pharmacodynamics and Efficacy of Pembrolizumab in Combination With Vorinostat in Patients With Advanced Prostate, Renal or Urothelial Carcinoma.

Roberto Pili et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.